Related Experiment Video

Updated: Oct 23, 2025

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
09:29

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

11.9K

Pulmonary talcosis in the setting of cosmetic talcum powder use

Alvin Cho1, Roxana Amirahmadi1, Aamir Ajmeri2

  • 1University of Maryland School of Medicine, Baltimore, MD, USA.

Respiratory Medicine Case Reports
|August 17, 2021
PubMed

Insights

Pulmonary talcosis, a rare lung disease, can result from inhaling talc. A comprehensive patient history is crucial for diagnosing this condition, even when caused by cosmetic powders.

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Occupational Health

Background:

  • Pulmonary talcosis is a rare pneumoconiosis with challenging diagnosis and potential for severe lung disease.
  • Literature describes four types: talc-silicosis, talc-asbestosis (industrial exposure), and talc-emboli (intravenous drug use).
  • Talc, common in household products, is often overlooked as a pneumoconiosis cause.

Observation:

  • This report details a rare case of talcosis in a woman who inhaled cosmetic face powder.
  • The patient developed symptoms two years after initial inhalation exposure.

Findings:

  • Cosmetic talcosis is exceptionally rare.
  • Comprehensive patient history is vital for diagnosing obscure cases of talcosis.

Implications:

  • Highlights the importance of considering talc exposure from non-traditional sources, like cosmetics.
  • Emphasizes the diagnostic value of detailed patient history in rare pulmonary diseases.
  • Suggests increased awareness of talc's potential respiratory risks beyond industrial settings.
Keywords:
FibrosisLung diseasePneumoconiosisTalcosis

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.2K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.5K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
424
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
690
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.0K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
538
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
245
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
494